This month we’re celebrating 40 years of funding telecoms research networks and the enduring success and connections made in this series of eight COST..
Achieving a good efficacy of chemotherapy is one of the major challenges still unresolved in oncological patients. The main limitation to the efficacy of chemotherapy is the multidrug-resistant (MDR) phenotype, a multiple cross-resistance towards different anticancer drugs.
It has been statistically shown that participating in COST Actions significantly increases the chance of success in making applications to other European programmes and acts as a career accelerator for young researchers.
COST Actions provide space to grow ideas in science and technology fields news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
This Topical Issue of EPJ A draws together a large collection of papers inspired by the theory of hot matter and relativistic heavy-ion collisions (THOR) European Cooperation in Science and Technology (COST) Action. Running between November 2016 and April 2021, THOR has provided a way for over 300 researchers involved in heavy-ion collision analysis to freely exchange their ideas.